108
Views
62
CrossRef citations to date
0
Altmetric
Research Article

Lymph Node Micrometastases in Head and Neck Cancer: A Review

Pages 660-665 | Published online: 08 Jul 2009

  • de Carvalho MB. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck 1998; 20: 16-21.
  • Leemans CR, Tiwari R, Nauta JJP, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node mtastases as a prognostic factor. Cancer 1994: 73: 187-90.
  • Leemans CR, Tiwari R, Nauta JJP, van der Waal I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993: 71: 452-6.
  • Ferlito A, Devaney KO, Devaney SL, Rinaldo A. What is the incidence of occult metastasis in patients with stage No cancers of the head and neck? [Editorial]. ORL J Otorhinolaryngol Relat Spec 2001: 63: 1-5.
  • Fardy MJ, Langdon JD. The changing pattern of oral cancer 1977-1995. Br J Oral Maxillofac Surg 1995: 33:
  • Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 1993: 166: 360-5.
  • Partridge M, Li S-R, Pateromichelakis S, Francis R, Phillips E, Huang XH, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000: 6: 2718-25.
  • Smeele LE, Leemans CR, Langendijk JA, Tiwari R, Slotman BJ, van der Waal I, et al. Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy. Head Neck 2000: 22: 559-63.
  • Knappe M, Louw M, Gregor RT. Ultrasonographyguided fine-needle aspiration for the assessment of cervical mtastases. Arch Otolaryngol Head Neck Surg 2000: 126: 1091-6.
  • Hermanek P, Hutter RVP, Sobin LH, Wittekind C. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668-73.
  • Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000: 6: 100-2.
  • International Union Against Cancer (UICC). TNM classification of malignant tumours, 5th edn. New York: Wiley-Liss. 1997.
  • Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995: 332: 429-35.
  • Feinmesser R, Freeman JL, Feinmesser M, Noyek A, Mullen BM. Role of modern imaging in decision-making for elective neck dissection. Head Neck 1992: 14: 173-6.
  • Don DM, Anzai Y, Lufkin RB, Fu Y-S, Calcaterra TC. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 1995; 105: 669-74.
  • Saka SM, MacDonald DG. Sampling of jugulo-digastric lymph nodes in oral cancer. J Oral Pathol Med 1989: 18: 123-4.
  • van den Brekel MWM, Stel HV, van der VaIk P, van der Waal I, Meyer CJLM, Snow GB. Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Otorhinolaryngol 1992: 249: 349-53.
  • Woolgar JA, Scott J, Vaughan ED, Brown JS. Pathological findings in clinically false-negative and falsepositive neck dissections for oral carcinoma. Ann R Coll Surg Engl 1994: 76: 237-44.
  • Woolgar JA, Beirne JC, Vaughan ED, Lewis Jones HG, Scott J, Brown JS. Correlation of histopathologic findings with clinical and radiologie assessments of cervical lymph-node mtastases in oral cancer. Int J Oral Maxillofac Surg 1995: 24: 30-7.
  • van den Brekel MWM, van der Waal I. Meijer CJLM, Freeman JL, Castelijns JA, Snow GB. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 1996; 106: 987-91.
  • Woolgar JA. Micrometastasis in oral oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J Oral Maxillofac Surg 1999; 37: 181-6.
  • Woolgar JA. Detailed topography of cervical lymphnode metastases from oral squamous cell carcinoma. Int J Oral Maxillofac Surg 1997: 26: 3-9.
  • Woolgar JA. Pathology of the NO neck. Br J Oral Maxillofac Surg 1999: 37: 205-9.
  • Ambrosch P, Kron M. Fischer G, Brinck U. Micrometastases in carcinoma of the upper aerodigestive tract: detection, risk of metastasizing. and prognostic value of depth of invasion. Head Neck 1995: 17: 473-9.
  • Ambrosch P, Brinck U. Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology (Hunting!) 1996: 10: 1221-9.
  • Enepekides DJ. Sultanem K. Nguyen C. Shenouda G. Black MJ, Rochon L. Occult cervical metastases. Immunoperoxidase analysis of the pathologically negative neck. Otolaryngol Head Neck Surg 1999: 120: 713-7.
  • Hamakawa H. Fukizumi M, Bao Y. Sumida T, Onishi A. Tanioka H. et al. Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer. Clin Exp Metastasis 1999: 17: 593-9.
  • Hamakawa H. Takemura K. Sumida T, Kayahara H. Tanioka H. Sogawa K. Histological study on pN upgrading of oral cancer. Virchows Arch 2000: 437: 11621.
  • Brennan JA. Sidransky D. Molecular staging of head and neck squamous carcinoma. Cancer Metastasis Rev 1996; 15: 3-10.
  • Partridge M. Head and neck cancer and precancer: can we use molecular genetics to make better predictions? Ann R Coll Surg Engl 1999; 81: 1-11.
  • Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I. Marshall F, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991: 252: 706-9.
  • Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992; 256: 102-5.
  • Schittek B, Bodingbauer Y, Ellwanger U, Blaheta HJ, Garbe C. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma. Br J Dermatol 1999; 141: 30-6.
  • Deguchi T, Yang M, Kawada Y. Micrometastasis of prostate cancer to lymph nodes: detection by means of reverse transcription-polymerase chain reaction. J Natl Cancer Inst 1997: 89: 1471-3.
  • Luketich JD, Kassis ES, Shriver SP, Nguyen NT, Schauer PR, Weigel TL, et al. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg 1998; 66: 1715-8.
  • Brakenhoff RH, Stroomer JG, ten Brink C, de Bree R, Weima SM, Snow GB, et al. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction. Clin Cancer Res 1999; 5: 72532.
  • Hamakawa H, Bao Y, Takarada M, Fukuzumi M, Tanioka H. Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: An immunocytochemical study with possible clinical relevance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998: 85: 438-43.
  • Hamakawa H, Fukuzumi M, Bao Y, Sumida T, Kayahara H, Onishi A, et al. Keratin mRNA for detecting micrometastasis in cervical lymph nodes of oral cancer. Cancer Lett 2000: 160: 115-23.
  • Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977; 40: 1621-8.
  • Suminami Y, Kishi F, Sekiguchi K, Kato H. Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 1991: 181: 51-8.
  • Schick C, Kamachi Y, Bartuski AJ, Cataltepe S, Schechter NM, Pemberton PA, et al. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J Biol Chem 1997: 272: 1849-55.
  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
  • Yashima K, Piatyszek MA, Saboorian HM, Virmani AK, Brown D, Shay JW, et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997: 50: 110-7.
  • Partridge M, Philips E, Francis R, Li SR. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC. J Pathol 1999; 189: 368-77.
  • Jung R, Petersen K, Krüger W, Wolf M, Wagener C, Zander A, et al. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 1999: 81: 870-3.
  • Ko Y. Klinz M, Totzke G. Gouni-Berthold I. Sachinidis A, Vetter H. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. Clin Cancer Res 1998: 4: 2141-6.
  • Ferlito A, Devaney KO, Rinaldo A. Is it time to develop an "ultrastaging system" for use in patients with head and neck malignancies? [Commentary]. Laryngoscope 2001; 111: 185-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.